AZTA
Price
$31.50
Change
-$0.55 (-1.72%)
Updated
Oct 16, 04:59 PM (EDT)
Capitalization
1.47B
33 days until earnings call
Intraday Buy/Sell Signals
BLFS
Price
$27.73
Change
-$1.02 (-3.55%)
Updated
Oct 16, 04:59 PM (EDT)
Capitalization
1.38B
21 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

AZTA vs BLFS

Header iconAZTA vs BLFS Comparison
Open Charts AZTA vs BLFSBanner chart's image
Azenta
Price$31.50
Change-$0.55 (-1.72%)
Volume$8.37K
Capitalization1.47B
BioLife Solutions
Price$27.73
Change-$1.02 (-3.55%)
Volume$12.21K
Capitalization1.38B
AZTA vs BLFS Comparison Chart in %
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTA vs. BLFS commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Hold and BLFS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (AZTA: $32.05 vs. BLFS: $28.76)
Brand notoriety: AZTA and BLFS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AZTA: 117% vs. BLFS: 258%
Market capitalization -- AZTA: $1.47B vs. BLFS: $1.38B
AZTA [@Pharmaceuticals: Other] is valued at $1.47B. BLFS’s [@Pharmaceuticals: Other] market capitalization is $1.38B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $156.16B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileBLFS’s FA Score has 1 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • BLFS’s FA Score: 1 green, 4 red.
According to our system of comparison, BLFS is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 5 TA indicator(s) are bullish while BLFS’s TA Score has 6 bullish TA indicator(s).

  • AZTA’s TA Score: 5 bullish, 2 bearish.
  • BLFS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, both AZTA and BLFS are a good buy in the short-term.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а -0.56% price change this week, while BLFS (@Pharmaceuticals: Other) price change was +5.19% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -3.27%. For the same industry, the average monthly price growth was -1.53%, and the average quarterly price growth was +13.93%.

Reported Earning Dates

AZTA is expected to report earnings on Nov 18, 2025.

BLFS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-3.27% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($1.47B) has a higher market cap than BLFS($1.38B). BLFS YTD gains are higher at: 10.786 vs. AZTA (-35.900). BLFS has higher annual earnings (EBITDA): 17.4M vs. AZTA (11.3M). AZTA has more cash in the bank: 319M vs. BLFS (81.8M). BLFS has less debt than AZTA: BLFS (23.8M) vs AZTA (52.6M). AZTA has higher revenues than BLFS: AZTA (669M) vs BLFS (93.5M).
AZTABLFSAZTA / BLFS
Capitalization1.47B1.38B107%
EBITDA11.3M17.4M65%
Gain YTD-35.90010.786-333%
P/E RatioN/AN/A-
Revenue669M93.5M716%
Total Cash319M81.8M390%
Total Debt52.6M23.8M221%
FUNDAMENTALS RATINGS
AZTA vs BLFS: Fundamental Ratings
AZTA
BLFS
OUTLOOK RATING
1..100
1714
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
10096
SMR RATING
1..100
9592
PRICE GROWTH RATING
1..100
5843
P/E GROWTH RATING
1..100
5112
SEASONALITY SCORE
1..100
n/a25

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZTA's Valuation (71) in the Electronic Production Equipment industry is in the same range as BLFS (99) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (96) in the Medical Specialties industry is in the same range as AZTA (100) in the Electronic Production Equipment industry. This means that BLFS’s stock grew similarly to AZTA’s over the last 12 months.

BLFS's SMR Rating (92) in the Medical Specialties industry is in the same range as AZTA (95) in the Electronic Production Equipment industry. This means that BLFS’s stock grew similarly to AZTA’s over the last 12 months.

BLFS's Price Growth Rating (43) in the Medical Specialties industry is in the same range as AZTA (58) in the Electronic Production Equipment industry. This means that BLFS’s stock grew similarly to AZTA’s over the last 12 months.

BLFS's P/E Growth Rating (12) in the Medical Specialties industry is somewhat better than the same rating for AZTA (51) in the Electronic Production Equipment industry. This means that BLFS’s stock grew somewhat faster than AZTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTABLFS
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
74%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEMIX44.19N/A
N/A
MFS Emerging Markets Equity I
SUVAX12.93N/A
N/A
PGIM Quant Solutions Large-Cap Val A
PNRZX69.19N/A
N/A
PGIM Jennison Natural Resources Z
MWECX38.24N/A
N/A
MFS Global Equity C
GSAFX28.08N/A
N/A
Goldman Sachs China Equity R6

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with IQV. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
+4.74%
IQV - AZTA
60%
Loosely correlated
-0.80%
RVTY - AZTA
59%
Loosely correlated
+1.08%
A - AZTA
59%
Loosely correlated
+1.17%
MTD - AZTA
59%
Loosely correlated
+0.07%
BRKR - AZTA
58%
Loosely correlated
-0.90%
More